About the Meeting
Antibiotic Resistance (‘ABR’) has featured heavily in the news, and has been a particular concern of the nation’s Chief Medical Officer. ABR has the potential to wipe out the future mortality/longevity improvements we might otherwise reasonably expect from general medical/lifestyle advances. In January 2017 the IFoA set up a working party to model the likely impact of ABR. In this session, members of the working party will present their findings (including plausible future scenarios and mortality/morbidity impacts), and describe the model produced by the working party (with associated UK parameterisation).
Speakers:
- Nicola Oliver, Mortality and Longevity Consultant, Medical Intelligence (UK) Ltd.
- Ross Hamilton, Pensions Consultant, Willis Towers Watson
Tickets available here
Related Events
(VIRTUAL) SIAS AGM followed by Talk on Climate Change
The SIAS Annual General Meeting will commence at 5.30pm and be followed by a talk on Climate Change, at 6pm.
Virtual
(VIRTUAL) ESG Investing
What ESG data and metrics should you be demanding from your asset manager?
The evolution of the relationship between institutional investor and asset manager in the context of climate change
Ov...